PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Precision Optics Corporation, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Precision Optics Corporation, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Growth Efficiency Ratio: Sales grew 22% in 3 years, but profit fell: $142 less profit per $100 of extra sales. Lower than 88% of Healthcare companies in United States.

Where $100 of sales goes

$129Operating costs$1.2Interest$30Net loss

Latest year (Jun 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-10.9×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 52% of Healthcare companies in United States.

Cash Locked Ratio

$26

For every $100 of sales, $26 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $22 tied up three years earlier.

More money tied up than 56% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 1/3

Sales grew in 1 of the last 3 years; profit grew in 1 of 3.

Less steady than 70% of Healthcare companies in United States.

Growth Efficiency Ratio

−$142

Sales grew 22% in 3 years, but profit fell: $142 less profit per $100 of extra sales.

Lower than 88% of Healthcare companies in United States.

Asset Productivity Ratio

+22% / +18%

In 3 years sales changed by +22% while total assets changed by +18%. Both moved at about the same pace.

Balance-sheet strength

Debt Due Cover Ratio

-6.1×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 57% of Healthcare companies in United States.

Cash Cushion Ratio

−1%

Debt, after subtracting cash, equals 1% of its market value (net debt).

Lower than 68% of Healthcare companies in United States.

Tangible Assets Ratio

54%

Of every $100 the company owns, $54 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 75% of Healthcare companies in United States.

Tangible Net Worth Ratio

26%

Of every $100 of net worth, $26 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 63% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+37%

Share count rose 37% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 51% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Precision Optics Corporation, Inc. made a loss over the last year. Precision Optics Corporation, Inc. owes $0.40 for every $1 it owns. Precision Optics Corporation, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Jun 2025.

P/E ratio

Loss

Precision Optics Corporation, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.31

The share price is 2.31 times Precision Optics Corporation, Inc.'s book value per share, lower than 53% of Healthcare companies in United States.

Market cap

$46 M

The total market value of all of Precision Optics Corporation, Inc.'s shares at today's price (share price × number of shares), smaller than 74% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$20 M

What Precision Optics Corporation, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

$1.83

Net worth divided by the number of shares. The share price of $4.23 is 2.3 times this, which is the P/B above.

Return on equity (ROE)

-22.3%

Precision Optics Corporation, Inc. lost 22.3% of its shareholders' money over the last year, higher than 65% of Healthcare companies in United States.

Owes vs Owns

0.40×

Precision Optics Corporation, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.

Dividend yield

None

Precision Optics Corporation, Inc. does not currently pay a dividend.

Revenue growth

-0%

Revenue fell 0% in the year to Jun 2025, and grew 7% a year on average over 3 years.

Profit growth

Loss

Precision Optics Corporation, Inc. made a loss in each of the last two years.

Profit margin

-30.3%

Precision Optics Corporation, Inc. lost $30 for every $100 of revenue.

Interest cover

Not covered

Precision Optics Corporation, Inc.'s operating profit did not cover its interest costs in the year to Jun 2025.

Cash vs debt

Net debt

Precision Optics Corporation, Inc. had $0 M more debt than cash (net debt) at Jun 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Precision Optics Corporation, Inc.: $46 M ÷ $20 M (31 Mar 2026) = 2.3.

What is Precision Optics Corporation, Inc.'s return on equity?

Precision Optics Corporation, Inc. lost 22.3% of its shareholders' money over the last year, higher than 65% of Healthcare companies in United States.

How much does Precision Optics Corporation, Inc. owe compared with what it owns?

Precision Optics Corporation, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.

Does Precision Optics Corporation, Inc. pay a dividend?

No. Precision Optics Corporation, Inc. does not currently pay a dividend.

Is Precision Optics Corporation, Inc.'s revenue growing?

Revenue fell 0% in the year to Jun 2025, and grew 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.